Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Altern Ther Health Med ; 29(5): 274-277, 2023 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-37083648

RESUMO

Objective: The prevalence of antimicrobial resistance in Helicobacter pylori (HP) infection has increased globally. This study aimed to compare the efficacy of Biling Weitong granules (BLWTG) combined with quadruple therapy in patients with refractory HP infection who had previously failed eradication therapy. Methods: This single-center prospective study enrolled patients with two or more consecutive failed HP treatments. A total of 122 patients with previously failed HP treatment from our hospital were recruited as participants and randomly (1:1) allocated to two eradication groups: patients treated with bismuth-containing quadruple therapy (esomeprazole 40 mg, amoxicillin 1.0 g, bismuth potassium citrate 220 mg, and clarithromycin 500 mg, twice daily [EACB group]) for 14 days. And those treated with BLWTG (5 g three times daily) combined with the EACB group for 14 days (BLWTG+EACB group). The therapeutic effects of the two treatment programs were comprehensively evaluated. Results: The study group had a significantly higher improvement rate in symptoms (dull stomach pain, nausea, gastric distension, loss of appetite, and belching) compared to the control group (P < .05). Eight weeks after drug withdrawal, the eradication rates in the control and study groups were 49.18% and 73.77%, respectively. The levels of interleukin-6, C-reactive protein, and tumor necrosis factor-α were significantly lower in both groups after treatment but were significantly lower in the study group than in the control group (P < .05). Conclusions: The combination of BLWTG and standard four-drug therapy had a high eradication rate and low recurrence rate in patients with refractory HP infection. Additionally, this combined therapy could regulate inflammatory reactions and reduce drug-related adverse reactions.


Assuntos
Infecções por Helicobacter , Helicobacter pylori , Humanos , Infecções por Helicobacter/tratamento farmacológico , Infecções por Helicobacter/etiologia , Bismuto/farmacologia , Bismuto/uso terapêutico , Antibacterianos/uso terapêutico , Antibacterianos/farmacologia , Estudos Prospectivos , Quimioterapia Combinada , Resultado do Tratamento , Amoxicilina/uso terapêutico , Amoxicilina/farmacologia
2.
Science ; 374(6569): 887-890, 2021 Nov 12.
Artigo em Inglês | MEDLINE | ID: mdl-34618547

RESUMO

Orbital data indicate that the youngest volcanic units on the Moon are basalt lavas in Oceanus Procellarum, a region with high levels of the heat-producing elements potassium, thorium, and uranium. The Chang'e-5 mission collected samples of these young lunar basalts and returned them to Earth for laboratory analysis. We measure an age of 1963 ± 57 million years for these lavas and determine their chemical and mineralogical compositions. This age constrains the lunar impact chronology of the inner Solar System and the thermal evolution of the Moon. There is no evidence for high concentrations of heat-producing elements in the deep mantle of the Moon that generated these lavas, so alternate explanations are required for the longevity of lunar magmatism.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA